JP2006525367A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525367A5
JP2006525367A5 JP2006514246A JP2006514246A JP2006525367A5 JP 2006525367 A5 JP2006525367 A5 JP 2006525367A5 JP 2006514246 A JP2006514246 A JP 2006514246A JP 2006514246 A JP2006514246 A JP 2006514246A JP 2006525367 A5 JP2006525367 A5 JP 2006525367A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
dihydroxy
compound
vitamin
cholecalciferol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006514246A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525367A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/013703 external-priority patent/WO2004098522A2/en
Publication of JP2006525367A publication Critical patent/JP2006525367A/ja
Publication of JP2006525367A5 publication Critical patent/JP2006525367A5/ja
Pending legal-status Critical Current

Links

JP2006514246A 2003-04-30 2004-04-30 ジェミニビタミンｄ３化合物及びその使用方法 Pending JP2006525367A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46663803P 2003-04-30 2003-04-30
PCT/US2004/013703 WO2004098522A2 (en) 2003-04-30 2004-04-30 Gemini vitamin d3 compounds and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2006525367A JP2006525367A (ja) 2006-11-09
JP2006525367A5 true JP2006525367A5 (https=) 2007-07-05

Family

ID=33434966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006514246A Pending JP2006525367A (ja) 2003-04-30 2004-04-30 ジェミニビタミンｄ３化合物及びその使用方法

Country Status (5)

Country Link
EP (1) EP1622455A4 (https=)
JP (1) JP2006525367A (https=)
AU (1) AU2004235775A1 (https=)
CA (1) CA2524026A1 (https=)
WO (1) WO2004098522A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192255A1 (en) * 2003-07-30 2005-09-01 Jin Tian Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular disease
CA2540325A1 (en) * 2003-09-24 2005-04-07 Bioxell Spa Methods for treating bladder dysfunction
US20070134286A1 (en) * 2004-12-02 2007-06-14 Wu-Wong Jinshyun R Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals
CN101198336A (zh) * 2005-03-23 2008-06-11 拜奥艾克塞尔股份公司 20－烷基双生维生素d3化合物及其使用方法
WO2006102647A1 (en) * 2005-03-23 2006-09-28 Bioxell S.P.A. 20-alkyl, gemini vitamin d3 compounds and methods of use thereof
US7286295B1 (en) 2005-11-30 2007-10-23 Sandia Corporation Microoptical compound lens
EP2063899A2 (en) * 2006-09-22 2009-06-03 Bioxell S.p.a. Use of vitamin d compounds for the prevention of adhesions
HUE073014T2 (hu) * 2007-04-25 2025-12-28 Opko Renal Llc Eljárás a másodlagos hyperparathyreoidismus biztonságos és hatékony kezelésére és megelõzésére krónikus vesebetegség esetén
WO2010082837A1 (en) * 2009-01-16 2010-07-22 Jan Anne Lyftogt Medicament for the treatment of pain and inflammation
CN104758300A (zh) * 2014-01-02 2015-07-08 上海泽生科技开发有限公司 维生素d及其组合物的抗菌用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE219483T1 (de) * 1997-04-28 2002-07-15 Hoffmann La Roche Vitamin d3 analoga mit bis-c-20-seitenketten
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
US6030962A (en) * 1997-04-28 2000-02-29 Synttex (U.S.A.) Inc. Vitamin D3 analogs with bis C-20 side chains
ATE322477T1 (de) * 1997-05-16 2006-04-15 Woman & Infants Hospital 3-epi-vitamin d2 verbindungen und ihre anwendungen
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
US20030095937A1 (en) * 2001-10-02 2003-05-22 Koeffler H. Philip Method for stimulating hair growth by administering vitamin D analogs

Similar Documents

Publication Publication Date Title
JP2007506765A5 (https=)
JP2006525367A5 (https=)
JP2007525494A5 (https=)
JP2009525981A5 (https=)
JP2016505019A5 (https=)
WO2006009092A1 (ja) 効果的な医薬の使用法及び副作用発現の防御に関する方法
US20180230102A1 (en) Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof
JP7395762B2 (ja) Ｊａｋキナーゼ関連疾患の治療のための薬物の調製におけるｊａｋ阻害剤の使用
JP2002541201A5 (https=)
ITMI981744A1 (it) Sali nitrati di farmaci
JP2008514621A5 (https=)
CN1246119A (zh) 吡咯并[3,4－d]－嘧啶酮衍生物及其作为药物的用途
EP1355876A1 (en) Methods of chemical synthesis of phenolic nitrogen mustard prodrugs
JP2007504128A5 (https=)
JP2008538114A5 (https=)
EP2222630A1 (en) Processes to pregabalin
EP2545917B1 (en) Novel ep4 agonist
JP5744003B2 (ja) 抗ウイルス化合物を調製する方法
CA2598518C (en) 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
SA518392275B1 (ar) -2h-مشتق 5- ميثيل -6- فينيل -4، 5- داي هيدرو بيريدازين -3- أون
WO2006129688A1 (ja) ２－アミノブタノール化合物及びその医薬用途
JP2009143931A (ja) テトラゾリルベンゾピランの製法
NZ570711A (en) 2-Substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof
CA2448518A1 (en) New compounds useful in reflux disease
AU2002309420A1 (en) New compounds useful in reflux disease